1. SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies. (15th July 2016) Authors: Cooles, F.A.H.; Anderson, A.E.; Drayton, T.; Harry, R.A.; Diboll, J.; Munro, L.; Thalayasingam, N.; Östör, A.J.K.; Isaacs, J.D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗